Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003801835 | SCV004597233 | pathogenic | Fetal akinesia deformation sequence 1; Congenital myasthenic syndrome 11 | 2023-06-23 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with RAPSN-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln245*) in the RAPSN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RAPSN are known to be pathogenic (PMID: 17686188). |
Baylor Genetics | RCV004573334 | SCV005054077 | likely pathogenic | Fetal akinesia deformation sequence 2 | 2024-03-17 | criteria provided, single submitter | clinical testing |